Compare ENLV & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | ZVIA |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 126.3M |
| IPO Year | 2014 | 2021 |
| Metric | ENLV | ZVIA |
|---|---|---|
| Price | $0.81 | $1.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $20.00 | $4.93 |
| AVG Volume (30 Days) | 281.6K | ★ 384.0K |
| Earning Date | 05-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.30 |
| Revenue Next Year | N/A | $6.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.01 |
| 52 Week Low | $0.43 | $1.11 |
| 52 Week High | $7.64 | $2.81 |
| Indicator | ENLV | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 61.16 |
| Support Level | $0.72 | $1.48 |
| Resistance Level | $0.94 | $1.51 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 19.59 | 100.00 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.